
𝐏𝐞𝐨𝐩𝐥𝐞 𝐌𝐨𝐯𝐞𝐬: Here's a look at some of November's notable new biopharma executive placement announcements - brought to you by @KleinHersh. Congrats to all on your new positions!

Daily biotech news, content, and exclusive interviews.

𝐏𝐞𝐨𝐩𝐥𝐞 𝐌𝐨𝐯𝐞𝐬: Here's a look at some of November's notable new biopharma executive placement announcements - brought to you by @KleinHersh. Congrats to all on your new positions!

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝟐𝟎𝟐𝟔: @Erasca is racing to be the next big story in the RAS space (in both pancreatic and lung) and believes it may have a best in class asset with high potency. $ERAS Full video: biotechtv.com/post/jefferies…

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝟐𝟎𝟐𝟔: The phase 3 OPERA-01 study of @OlemaOncology's CERAN + SERD, palazestrant, is setting up to be one of biotech's key readouts and is quickly approaching and scheduled to read in 1Q27. $OLMA Full video: biotechtv.com/post/jefferies…


𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝟐𝟎𝟐𝟔: @Marea_tx CEO Josh Lehrer describes the ANGPTL4 target for targeting triglycerides (Marea is first in class) and compares and contrasts it to ANGPTL3 and APOE3. Full video: biotechtv.com/post/jefferies…

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝟐𝟎𝟐𝟔: @Jefferies Biotech Analyst Faisal Khurshid shares his take on biotech and companies he covers - from a London Black Cab! $RVMD $SMMT $ABVX $KYMR $COGT Watch the full video: biotechtv.com/post/jefferies…

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝟐𝟎𝟐𝟔: A top biotech CEO (@Roivant's @gline) and top investor (Affinity Asset Advisors' @pnosker) talk running biotech companies and investing in them. $ROIV Watch the full discussion: biotechtv.com/post/jefferies…

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝟐𝟎𝟐𝟔: With two FDA filings under review and other programs in late stage, @PraxisMedicines is in a pivotal moment - CEO Marcio Souza updates us on all the moving pieces. $PRAX Full video: biotechtv.com/post/jefferies…

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝟐𝟎𝟐𝟔: @CRISPRTX's CEO @CrisprSam walks us through the company's increasingly advancing pipeline, which includes an siRNA. $CRSP Full video: biotechtv.com/post/jefferies…

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝟐𝟎𝟐𝟔: @ProtagonistTx's CEO Dinesh Patel discusses the launch of ICOTYDE, and the company's pipeline, which is well funded now due to commercial success. $PTGX Full video: biotechtv.com/post/jefferies…

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧 𝟐𝟎𝟐𝟔: @valnevaSE CEO Thomas Lingelbach shares an update on the status of the company's Lyme disease program (partnered with Pfizer) and more pipeline projects. $VALN Full video: biotechtv.com/post/jefferies…

𝐇𝐋𝐓𝐇 𝐔𝐒𝐀 𝟐𝟎𝟐𝟔: @AbbottNews's Chief Medical Officer for Multi-Cancer Detection describes the science behind multi-cancer early detection tests and shares his thoughts on where the field is headed. Full video: biotechtv.com/post/hlth-usa-…

𝐋𝐨𝐧𝐝𝐨𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐖𝐞𝐞𝐤: Today @FlagshipPioneer announced Flagship Origination Lab in London to create AI-native companies - Flagship's first company creation lab outside of Cambridge, MA. Flagship Founder & CEO @NoubarAfeyan tells us more.

Tomorrow at Jefferies London on @BiotechTV, we have interviews with $PTGX, $CRSP, $PRAX, $ROIV, Marea Therapeutics, and more. Let us know any questions you'd like us to ask them.

Join us once again for the best social event at JPM!
#BiotechHangout & @BiotechTV are heading back to San Francisco for #JPM27! Join us for a night of in-person mingling with Biotech Hangout hosts & friends at Persona (same location as previous years) on Tuesday, January 12, 2027, from 7-10pm PT. A special thanks to our returning co-sponsors CFGO and @FTIConsulting, who signed on early to support the event again this year. Interested in sponsoring the event? Send us an email at team@biotechhangout.com. Space is limited, so reach out soon. RSVP to the event here: forms.gle/tSb6dFHYzP8SvgKs7 All are welcome & we hope to see you there! #JPMHangout
View quoted post ↗
𝐇𝐋𝐓𝐇 𝐔𝐒𝐀 𝟐𝟎𝟐𝟔: @chloeckirk is in Las Vegas at #HLTHUSA 2026 for BiotechTV. Catch her interviews with healthcare leaders over the next couple of days! @HLTHEVENT